Emmessar Biotech & Nutrition Limited
BSE: EMMESSA.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mathurakavi Srinivasa Raghavan Ayyangar
- Employees
- 17
- Headquarters
- Mumbai, India
- IPO year
- 2024
- Market cap
- ₹127.0M
- Website
- http://www.ebnl.org
Loading EMMESSA…
Loading profile data…Frequently asked questions about EMMESSA
What does Emmessar Biotech & Nutrition Limited (EMMESSA.BO) do?
Emmessar Biotech & Nutrition Ltd. engages in the manufacture and marketing of healthcare and nutritional products. The company operates through the following segments: Healthcare, Fine Chemicals, and Rent on Lease Land. It sells products for skin cure and care, general health, muscle and bone care, pain relief, and sexual health. The company was...
Where does EMMESSA.BO trade?
Emmessar Biotech & Nutrition Limited (EMMESSA.BO) trades on the Bombay Stock Exchange.
What sector is EMMESSA.BO in?
Emmessar Biotech & Nutrition Limited (EMMESSA.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Emmessar Biotech & Nutrition Limited?
Mathurakavi Srinivasa Raghavan Ayyangar is the chief executive officer of Emmessar Biotech & Nutrition Limited (EMMESSA.BO).
Where is Emmessar Biotech & Nutrition Limited headquartered?
Emmessar Biotech & Nutrition Limited is headquartered in India.
Does EMMESSA.BO pay a dividend?
Emmessar Biotech & Nutrition Limited (EMMESSA.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EMMESSA.BO go public?
Emmessar Biotech & Nutrition Limited (EMMESSA.BO) completed its initial public offering in 2024.